Atlantic Trust Group LLC trimmed its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 9.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,311 shares of the medical equipment provider’s stock after selling 2,346 shares during the period. Atlantic Trust Group LLC’s holdings in Zimmer Biomet Holdings were worth $2,735,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MARSHALL WACE ASIA Ltd acquired a new stake in Zimmer Biomet Holdings during the 1st quarter valued at $38,621,000. Cibc World Markets Corp grew its holdings in Zimmer Biomet Holdings by 52.9% during the 1st quarter. Cibc World Markets Corp now owns 21,007 shares of the medical equipment provider’s stock valued at $2,565,000 after purchasing an additional 7,269 shares in the last quarter. Caxton Associates LP acquired a new stake in Zimmer Biomet Holdings during the 1st quarter valued at $403,000. Bank of Nova Scotia grew its holdings in Zimmer Biomet Holdings by 933.9% during the 1st quarter. Bank of Nova Scotia now owns 45,996 shares of the medical equipment provider’s stock valued at $5,616,000 after purchasing an additional 41,547 shares in the last quarter. Finally, Neuberger Berman Group LLC grew its holdings in Zimmer Biomet Holdings by 16.4% during the 2nd quarter. Neuberger Berman Group LLC now owns 1,480,467 shares of the medical equipment provider’s stock valued at $190,092,000 after purchasing an additional 208,881 shares in the last quarter. 85.48% of the stock is owned by institutional investors and hedge funds.

Zimmer Biomet Holdings, Inc. (ZBH) opened at 115.70 on Friday. The company has a market capitalization of $23.39 billion, a P/E ratio of 32.95 and a beta of 1.21. Zimmer Biomet Holdings, Inc. has a 52-week low of $95.63 and a 52-week high of $133.49. The stock has a 50 day moving average of $116.64 and a 200-day moving average of $120.78.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Zacks’ consensus estimate of $2.10 by $0.02. The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. Zimmer Biomet Holdings’s revenue was up 1.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.02 earnings per share. On average, equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is currently 27.59%.

In related news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Sang Yi sold 17,731 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total value of $2,208,573.36. The disclosure for this sale can be found here. 1.07% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Zimmer Biomet Holdings, Inc. (ZBH) Position Trimmed by Atlantic Trust Group LLC” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/09/zimmer-biomet-holdings-inc-zbh-position-trimmed-by-atlantic-trust-group-llc.html.

A number of equities research analysts recently weighed in on the stock. Morgan Stanley raised their price target on shares of Zimmer Biomet Holdings from $137.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, July 17th. Stifel Nicolaus reaffirmed a “hold” rating and set a $125.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $141.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Wells Fargo & Company reaffirmed a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $140.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Zimmer Biomet Holdings presently has an average rating of “Hold” and an average target price of $136.75.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.